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Abstract
Background: Fast and accurate chest pain risk stratification in the emergency department (ED) is critical. The HEART
score predicts the short-term incidence of major adverse cardiac events (MACE) in this population, dividing it in three
risk categories. We aimed to describe the population with chest pain, to characterize the subgroup of patients with
acute coronary syndrome (ACS) and to assess the prognostic value of Manchester triage system and of HEART score.
Methods: Retrospective observational study including patients admitted to the ED of a tertiary hospital with chest
pain as the presenting symptom. The primary outcome was a composite of all-cause mortality, myocardial infarction or
unscheduled revascularization at 6 weeks.
Results: We enrolled 233 patients (age 58 ± 19; 55.4 % males). The most common final diagnosis was non-specific
chest pain (n = 86, 36.9 %), followed by ACS (n = 22, 9.4 %). Male gender, smoking and chronic kidney disease were
associated with higher risk of ACS. According to Manchester triage system, chest pain patients stratified with red
or orange priority had a higher incidence of ACS (16.5 % vs. 3.8 %, p = 0.006). The application of HEART score showed
that most patients were in low risk category (56.3 %). The six-week incidence of MACE in each category was 2 %,
15.6 % and 76.9 % (p < 0.001). HEART score accurately predicted the short-term incidence of MACE in chest pain
patients (c-statistic 0.880; 95 % CI, 0.807–0.950, p < 0.001).
Conclusions: Chest pain patients have very different levels of severity and the discriminatory power of Manchester
triage system should be used in the assessment of this population. The HEART score seems to be an effective tool for
risk stratification in the ED.
Keywords: Chest pain, Emergency department, Manchester triage system, HEART score, Acute coronary syndrome,
Angina pectoris
Background
Chest pain management is one of the biggest challenges
in the emergency department (ED). This symptom ac-
counts for 5 to 20 % of all ED admissions [1], being the
second most common reason to present to the ED in
the United States of America [2]. Causes of chest pain
range from musculoskeletal chest pain to potentially life-
threatening emergencies as acute coronary syndrome
(ACS), aortic dissection or pulmonary embolism. Therefore,
accurate and fast risk stratification is paramount in the
acute management of these patients, mainly to identify
those patients with immediate risk of complications, as
those with an ACS. This group of patients is challen-
ging to discriminate, as there is a variety of clinical
manifestations.
To minimize this problem, several risk stratifying tools
have been developed in the last years. Some of these
tools are applicable to all clinical situations presenting to
the ED, as the Manchester triage system. This validated
system is performed by specifically trained nurses and
prioritize patients according to illness severity and is based
on the main complaint and in the presence of certain
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discriminators, according to a structured questionnaire
[3]. A colour is assigned to each level of urgency, spe-
cifying a target time to first medical observation: red
(immediate); orange (<10 min); yellow (<60 min); green
(<120 min) and blue (<240 min).
Other systems, more selective, are devoted to the risk
stratification of suspected ACS in the ED. One is the
HEART score, designed to be performed by the ED
physician, predicting the short-term occurrence of major
adverse cardiac events (MACE) - all-cause death, myo-
cardial infarction or revascularization – in the ED popu-
lation of chest pain patients [4].
We aimed (1) to describe an unselected population of
chest pain patients presenting to the ED; (2) to characterize
the subgroup of patients diagnosed with an ACS and (3) to
determine the value of Manchester triage system and
HEART score for risk stratification in acute chest pain.
Methods
Study design
We conducted a retrospective cohort study, which in-
cluded all patients admitted to the ED of a tertiary refer-
ral hospital, with non-traumatic chest pain as the chief
complaint. This ED receives around 400 to 500 patients
daily, having no dedicated chest pain unit. There was no
exclusion criterion in the selection of patients.
All clinical, laboratory and imaging data were recorded
in a proprietary software specially developed for ED
environments (ALERT®, ALERT systems, Vila Nova de
Gaia, Portugal). In our ED, all patients are stratified by
priority using a risk stratification protocol - the Man-
chester triage system - performed by specifically trained
nurses. From the data introduced in ALERT®, we col-
lected clinical information from the ED patients, ana-
lysed the level of priority given, prior medical history,
diagnostic tests results and the final diagnosis. Accord-
ing to the diagnosis made by the ED cardiologist, using
the current definition [5], patients were divided into two
groups: group 1 – established ACS diagnosis; group 2 – no
ACS. Nevertheless, every patient admitted to in-hospital
care was reviewed by the authors to confirm the diagnosis.
The research protocol was approved by the local ethics
committee (Comissão de Ética para a Saúde do Centro
Hospitalar e Universitário de Coimbra).
ACS risk-stratifying systems
The HEART score was retrospectively applied to the
population according to the information available in the
ALERT® system and in the electronic health records of
the hospital. The acronym HEART is an abbreviation of
the five parameters evaluated [6]:
– History (highly suspicious – 2 points; moderately
suspicious – 1 point; slightly suspicious – 0 points)
– ECG (significant ST-depression – 2 points;
non-specific repolarization disturbance – 1 point;
normal – 0 points)
– Age (≥65 years – 2 points; 45–65 years – 1 point;
≤ 45 years – 0 points)
– Risk factors for coronary heart disease (≥3 risk
factors – 2 points; 1 or 2 risk factors – 1 point;
no risk factors – 0 points)
– Troponin (≥3 times the threshold for positivity – 2
points; 1 to 3 times the threshold for positivity – 1
point; normal limit – 0 points)
Two independent authors, blinded to the final diagnosis,
performed the classification of the degree of suspicion in
the ‘history’ parameter. In the cases with two different
scores, the mean value was considered. The ECG’s were
interpreted by the attending physician in the ED, specialist
in internal medicine or in cardiology.
According to the total score received, patients are
divided into low (0–3), intermediate (4–6) or high (7–10)
risk of a MACE, within 6 weeks after presentation at the
ED. Lower scores lead to a recommendation of early
discharge, intermediate scores suggest clinical observation
or performance of non-invasive investigations and high
scores admission for more invasive strategies [4]. In the
analysis of HEART score data, we only used patients with
available records to complete all the five parameters of the
score, excluding patients without ECG or troponin meas-
urement. This has led to a dropout of 59 patients (25.3 %).
A 6-week follow-up of all patients was conducted
through the electronic health records information of the
hospital and through direct phone calls to the patients
involved. The follow-up focused on the composite end-
point of MACE, comprising all-cause death, myocardial
infarction or unscheduled revascularization. No patient
was lost to follow-up.
Statistical analysis
We aimed to find a difference in 6-week MACE between
low, intermediate and high risk categories of HEART
score. Based on the proportions of the multicentre study
of Backus et al. [4] and assuming an alpha of 0.05, we
would need a sample of 168 patients to detect dif-
ferences with 80 % power. Since we anticipate that
20–25 % of patients could not have records to complete
all the parameters of the score, we aimed for a sample size
of 220 patients. The period of time analysed included 1
week from winter (23rd to 29th January 2012) and 1 week
from summer (23rd to 29th July 2012), randomly selected,
in order to balance the list of final diagnosis. Statistical
analysis was carried out using IBM SPSS Statistics for
Windows software version 20.0® (Armonk, New York).
Normality of continuous variables was tested by histogram
observation and Kolmogorov-Smirnov test. Continuous
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variables are presented by mean ± standard deviation
and categorical variables as percentage. We used Stu-
dent’s T test and Mann–Whitney test for comparison of
means for continuous variables, Chi-square and Fisher’s
exact test for comparison of categorical variables.
Multiple logistic regression adjusted for confounding
factors was performed considering any variable with
p < 0.25 in univariate analysis. A received operator
characteristics (ROC) curve was used to determine the
discriminatory power of HEART score. Results with
p < 0.05 were considered as statistically significant.
Results
Characterization of the chest pain population in the ED
We evaluated 233 patients presenting with non-traumatic
chest pain, which accounted for 4.2 % of all ED admis-
sions. The demographic characteristics and the priority
stratification according to Manchester triage system are
shown on Table 1. Age ranged from 19 to 98 years and
women were significantly older than men (60.7 ± 20 vs.
55.4 ± 13, p = 0.012).
The most frequently requested diagnostic tests were
chest X-ray (85.4 %), ECG (81.5 %) and cardiac bio-
markers (74.2 %). The median time from patient ED
arrival to ECG acquisition was 20 (IQR 12–41) minutes.
According to Manchester triage system, patients strati-
fied with a red or orange priority performed the ECG
significantly faster than those with yellow or green prior-
ity (median 15 vs. 28 min, p < 0.001)
As presented in Fig. 1, after clinical observation and in-
terpretation of diagnostic tests, the most common diagno-
sis made by the attending physician was non-specific chest
pain (n = 86, 36.9 %), followed by ACS (n = 22, 9.4 %),
anxiety-depressive disorder (n = 21, 9.0 %) and respiratory
infection (n = 20, 8.6 %). The group of the less frequent
diagnosis (10.3 %) included: cardiovascular diseases, as
aortic dissection or acute pericarditis; pulmonary diseases,
as acute asthma; and gastrointestinal diseases, as gastro-
oesophageal reflux disease or biliary colic.
Stratifying the final diagnosis by season of the year, we
found a higher proportion of patients being diagnosed
with respiratory infections in the winter than in summer
(15.9 % vs. 1.7 %, p <0.001), whereas the proportion of
the other final diagnosis, like non-specific chest pain or
ACS, were similar in both seasons.
The great majority of patients presenting in the ED
with chest pain were discharged home (n = 189, 81.1 %),
while the remaining were admitted to hospital (n = 44,
18.9 %). The incidence of the composite endpoint of
MACE was 9.4 %.
The patient flow diagram is summarized in Fig. 2.
Subgroup of acute coronary syndrome patients
Among the group of patients with a final diagnosis of
ACS (group 1, n = 22), the most common ACS subtype
was unstable angina (10 patients - 46 %), followed
by non-ST-elevation myocardial infarction (NSTEMI)
(7 patients - 32 %) and ST-elevation myocardial infarc-
tion (STEMI) (5 patients - 23 %). Group 1 patients were
older and had a higher proportion of males, compared
with the group of patients without ACS. Moreover, they
had a significantly higher prevalence of hypertension,
type 2 diabetes, dyslipidaemia, smoking habits, pre-
viously known coronary artery disease and chronic
kidney disease (Table 2).
The great majority of patients diagnosed with an ACS
were given high priorities by the Manchester triage system,
with only 1 patient given the colour green (4.5 %). Most
patients were classified as orange (n = 16, 72.8 %), followed
by yellow (n = 4, 18.2 %) and red (n = 1, 4.5 %). The five
STEMI patients were triaged with orange (n = 4, 80 %)
or red (n = 1, 20 %) priority, while the seven NSTEMI
patients were triaged as orange (n = 6, 85.7 %) or green
(n = 1, 14.3 %).
There was a correlation between Manchester’s priority
category in chest pain patients and the final diagnosis of
ACS: 3.2 % in the green category, 4.0 % in the yellow cat-
egory, 15.7 % in the orange category and 100.0 % in the red
category. Patients stratified red or orange had a significantly
higher incidence of ACS compared with those with yellow
or green levels of priority (16.5 % vs. 3.8 %, p = 0.006).
Table 1 Demographic characteristics and Manchester triage
system
Variable
Age, mean ± SD 57.7 ± 19
Male gender, n (%) 129 (55.4)
Manchester triage system, n (%)
- Red 1 (0.4)
- Orange 102 (43.8)
- Yellow 99 (42.5)
- Green 31 (13.3)
Past medical history, n (%)
- Hypertension 125 (53.6)
- Dyslipidemia 90 (38.6)
- Type 2 diabetes 33 (14.2)
- Active smoker 31 (13.3)
- Coronary artery disease 36 (15.5)
- Atrial fibrillation 42 (18)
- Heart failure 38 (16.3)
- Chronic pulmonary obstructive disease 16 (6.9)
- Chronic kidney disease 11 (4.7)
- Others 31 (13.3)
SD standard deviation
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Using a multivariate analysis model controlling for
age, gender, hypertension, dyslipidaemia, type 2 diabetes,
smoking, coronary artery disease and chronic kidney dis-
ease, male gender (odds-ratio (OR) 4.48; 95 % confidence
interval (CI), 1.12–17.40; p = 0.030), smoking (OR 4.22;
95 % CI, 1.21–14.74; p = 0.024) and chronic kidney disease
(OR 8.21; 95 % CI, 1.76–38.16; p = 0.007) emerged as inde-
pendent predictors of ACS in this population.
The use of HEART score in risk stratification
The determination of the HEART score in the population
with complete datasets (n = 174) showed that most chest
pain patients were low risk (n = 98, 56.3 %), followed by
intermediate (n = 64, 36.7 %) and high risk (n = 12, 6.9 %).
Figure 3 illustrates the relationship between the HEART
score and the incidence of the composite endpoint, with
higher scores associated with higher incidence of 6-week
MACE.
When the three externally validated categories of the
HEART score were used (low risk 0–3; intermediate risk
4–6; high risk 7–10), a good discrimination of the inci-
dence of 6-week MACE was obtained (2 %, 15.6 % and
76.9 %, p < 0.001), as showed in Fig. 4.
The HEART score had a good discriminatory power
(c-statistic 0.880; 95 % CI, 0.807 – 0.950, p < 0.001) to
predict the probability of the composite endpoint. The
sensitivity, specificity, positive and negative predictive
values for the established cut-off scores of 4 and 7 are
shown in Table 3.
Discussion
In this study we described a population of patients pre-
senting to an ED with chest pain as their main com-
plaint. We demonstrated that less than 10 % have an
ACS as the aetiology basis of this symptom and that the
Manchester triage system correctly prioritized the pa-
tients with most severe causes of pain. Finally, we retro-
spectively tested the HEART score in our population,
demonstrating that it has a good discriminatory power
to identify the risk of MACE in a short term period.
Figure 1 Final diagnosis of patients. COPD, chronic obstructive pulmonary disease
233 patients presenting with chest pain
(44 admitted; 189 discharged)
22 patients with ACS
(9.4%)
211 patients without ACS 
(90.6%)
19 patients with MACE 
within 6 weeks (86.4%)
3 patients with MACE 
within 6 weeks (1.4%)
HEART score analysis
(59 patients excluded)
Figure 2 Flow diagram of patients presenting with chest pain. ED, emergency department; ACS, acute coronary syndrome; MACE, major adverse
cardiovascular events
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Our sample presented a male predominance, a wide
range of age and a mean age similar to previous studies
[7–9]. The analysis of the Manchester triage system in
this population showed that more than a half of the
patients were stratified with a green or a yellow level of
severity, in accordance with the high incidence of poten-
tially benign causes of chest pain. The most frequent
comorbidities were similar to other studies [7, 9]; how-
ever we found a higher prevalence of hypertension and
lower proportion of active smokers.
Considering the diagnostic tests, and in comparison
with the results of the Spanish study of Martínez-Sellés
et al. [7], our ED physicians requested more chest X-rays
and cardiac biomarkers in this sample. The ECG is a
first-line diagnostic tool in chest pain assessment and
the time from ED arrival to ECG acquisition in this
cohort was greater than the 10 min recommended in the
current European Society of Cardiology guidelines [5].
Therefore, an effort must made to shorten this time, in
order to identify life-threatening emergencies, namely to
reduce time to revascularization therapy in STEMI.
The final diagnostic list of this population was extensive,
with very different levels of severity, as in the literature
[10]. Non-specific chest pain (mostly musculoskeletal
pain) was the most frequent diagnosis, but with a propor-
tion slightly lower than that reported in other studies,
were it ranges from 43 to 59 % [7, 11]. This diagnosis is
thus probably the most frequent one in an unselected
population. ACS represented the second most common
final diagnosis of chest pain in our population, albeit with
a lower percentage than that reported in the literature
(15.7 %) [7]. Stable angina had a relatively low proportion
(2.6 %) on the list of the final diagnosis. Although this per-
centage is only slightly lower than in other studies [7], this
clinical presentation of coronary artery disease may be
underdiagnosed as non-specific chest pain.
Our study reports some traditional cardiovascular risk
factors [12] that can increase significantly the odds of
chest pain being of unstable coronary artery disease ori-
gin, as male gender, smoking and chronic kidney disease.
Considering the Manchester triage system, most of ACS
patients were stratified with an orange or red level of pri-
ority, but this percentage was slightly lower than in previ-
ous studies [13, 14]. Although the proportion of patients
stratified as yellow or green (n = 5, 22.7 %) could lead to
an important delay in the management of ACS, namely in
the time from arrival to ECG acquisition, none of these
cases were STEMI, a reassuring finding that highlights the
clinical value of the triage system. Taking in consideration
all chest pain patients in the ED, the proportion of ACS is
significantly higher in orange or red priority patients, in
comparison to green or yellow, showing that the Man-
chester triage system has a reasonable discriminatory
power. Our data are in line with another Portuguese
cohort, where the sensitivity of this system in assigning red
or orange priority to patients with ACS was 87.3 % [13].
Table 2 Comparative of population characteristics ACS versus no ACS
Group 1 – ACS (n = 22) Group 2 – No ACS (n = 211) p
Age, mean ± SD 65.6 ± 15 56.9 ± 19 0.043
Male gender, n (%) 18 (81.8) 111 (52.6) 0.012
Hypertension, n (%) 18 (81.8) 107 (50.7) 0.006
Dyslipidemia, n (%) 17 (73.9) 73 (34.6) 0.001
Type 2 diabetes, n (%) 8 (36.4) 25 (11.8) 0.005
Smoking, n (%) 8 (36.4) 23 (10.9) 0.003
Coronary artery disease, n (%) 9 (40.9) 27 (12.7) 0.002
Atrial fibrillation, n (%) 3 (13.6) 39 (18.5) 0.773
Heart failure, n (%) 3 (13.6) 35 (16.6) 0.957
Chronic pulmonary obstructive disease, n (%) 1 (4.5) 16 (7.6) 0.376
Chronic kidney disease, n (%) 5 (22.7) 6 (2.8) 0.002
ACS acute coronary syndrome, SD standard deviation
Figure 3 Incidence of 6-week MACE in each HEART score. MACE,
major adverse cardiovascular events
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In search for the optimal risk stratifying system for
chest pain patients, we analysed the HEART score. This
score was developed as an attempt to create an easy-to-
use ACS risk quantification, incorporating well known
markers of increased risk available on the ED, allowing a
more firmly based decision, mainly in cases of atypical
presentation or absence of ECG abnormalities [6]. The
application of the HEART score to our population
showed that the majority of patients are low risk, as it
was reported in the first cohort where this score was ap-
plied [6]. The relationship between the HEART category
and adverse outcomes, defined as the occurrence of
MACE within 6 weeks, showed a curve with three differ-
ent patterns, corresponding to the three risk categories
defined by the literature [15]. The risk stratification
using the three categories (0–3; 4–6; 7–10) identified
MACE with similar proportions than in the multicentre
study of Backus et al. [4], but with greater risk of MACE
in the high risk category.
Our study confirmed the appropriate discriminatory
power of the three risk categories of HEART score to
predict short-term occurrence of MACE. A score <4,
corresponding to low risk category, had a very high
negative predictive value, identifying a small risk
population. Moreover, the high risk category (score
≥7) showed a reasonable positive predictive value,
allowing the identification of a high risk population,
even in patients with more atypical presentations.
This risk score may help in making accurate man-
agement choices in a setting that is frequently de-
noted by uncertainty, by being a strong predictor of
event free survival and of potentially life threatening
cardiac events.
The limitations of this study are mainly those inher-
ent to single-centre retrospective studies. The pre-
valence of obesity, an important cardiovascular risk
factor, was not analysed because of lack of data about
body mass index. In the analysis of HEART score, we
only used patients with all the five parameters available
to complete the score, which could lead to a selection
bias. However, when comparing the characteristics of
the patients with incomplete datasets with patients
with complete datasets, no differences were found in
the available variables. We are unaware of studies
where the HEART score has been applied prospectively
in real time, but such studies would be useful to con-
firm the prognostic value of the score. Furthermore,
during the period of time analysed, the laboratory was
using conventional troponin I assays, so we could not
evaluate the potential impact of high-sensitivity tropo-
nin in chest pain management.
Conclusions
Chest pain is a common complaint in the ED and has an
extensive differential diagnosis list with very different
levels of severity. Age, gender, traditional cardiovascular
risk factors and the priority attributed by the Manches-
ter triage system should be considered in the assessment
of patients. Moreover, the HEART score seems to be a
useful tool for risk stratification and decision making in
acute chest pain.
Figure 4 Incidence 6-week MACE in each HEART score risk category. MACE, major adverse cardiovascular events
Table 3 Sensitivity, specificity, positive and negative predictive
values for six-week incidence of MACE using HEART score
Cut-off = 4a Cut-off = 7b
Sensitivity, % [95 % CI] 90.9 [70.8; 98.9] 45.5 [24.4; 67.79]
Specificity, % [95 % CI] 63.2 [55.0; 70.8] 98.7 [95.3; 99.8]
Positive predictive
value, % [95 % CI]
26.3 [16.9; 37.7] 83.3 [51.59; 97.9]
Negative predictive
value, % [95 % CI]
97.9 [92.8; 99.8] 92.6 [87.4; 96.1]
a98 patients with score <4 and 76 with score ≥4
b162 patients with score <7 and 12 with score ≥7
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